Table of Contents Author Guidelines Submit a Manuscript
Journal of Parasitology Research
Volume 2009, Article ID 818296, 4 pages
http://dx.doi.org/10.1155/2009/818296
Case Report

Fatal Outcome of Disseminated Strongyloidiasis despite Detectable Plasma and Cerebrospinal Levels of Orally Administered Ivermectin

1Lexington Infectious Disease Consultants, Lexington, KY 40503, USA
2Department of Pharmacy, University of Kentucky, Lexington, KY 40504, USA
3Commonwealth Neurology, Lexington, KY 40503, USA
4University of Iowa College of Pharmacy, Iowa City, IA 52242, USA

Received 15 December 2008; Accepted 6 February 2009

Academic Editor: Domenico Otranto

Copyright © 2009 Charles E. Rose III et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Albonico, D. W. T. Crompton, and L. Savioli, “Control strategies for human intestinal nematode infections,” Advances in Parasitology, vol. 42, pp. 277–341, 1998. View at Publisher · View at Google Scholar
  2. M. Segarra-Newnham, “Manifestations, diagnosis, and treatment of Strongyloides stercoralis infection,” Annals of Pharmacotherapy, vol. 41, no. 12, pp. 1992–2001, 2007. View at Publisher · View at Google Scholar · View at PubMed
  3. P. B. Keiser and T. B. Nutman, “Strongyloides stercoralis in the immunocompromised population,” Clinical Microbiology Reviews, vol. 17, no. 1, pp. 208–217, 2004. View at Publisher · View at Google Scholar
  4. M. Walker and J. R. Zunt, “Parasitic central nervous system infections in immunocompromised hosts,” Clinical Infectious Diseases, vol. 40, no. 7, pp. 1005–1015, 2005. View at Publisher · View at Google Scholar · View at PubMed
  5. A. A. Siddiqui and S. L. Berk, “Diagnosis of Strongyloides stercoralis infection,” Clinical Infectious Diseases, vol. 33, no. 7, pp. 1040–1047, 2001. View at Publisher · View at Google Scholar · View at PubMed
  6. E. Gotuzzo, A. Terashima, H. Alvarez et al., “Strongyloides stercoralis hyperinfection associated with human T cell lymphotropic virus type-1 infection in Peru,” The American Journal of Tropical Medicine and Hygiene, vol. 60, no. 1, pp. 146–149, 1999. View at Google Scholar
  7. Y. Igra-Siegman, R. Kapila, P. Sen, Z. C. Kaminski, and D. B. Louria, “Syndrome of hyperinfection with Strongyloides stercoralis,” Reviews of Infectious Diseases, vol. 3, no. 3, pp. 397–407, 1981. View at Google Scholar
  8. T. Cruz, G. Reboucas, and H. Rocha, “Fatal strongyloidiasis in patients receiving corticosteroids,” The New England Journal of Medicine, vol. 275, no. 20, pp. 1093–1096, 1966. View at Google Scholar
  9. H. P. Hauber, J. Galle, P. L. Chiodini et al., “Fatal outcome of a hyperinfection syndrome despite successful eradication of Strongyloides with subcutaneous ivermectin,” Infection, vol. 33, no. 5-6, pp. 383–386, 2005. View at Publisher · View at Google Scholar · View at PubMed
  10. H. Marti, H. J. Haji, L. Savioli et al., “A comparative trial of a single-dose ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil-transmitted helminth infections in children,” The American Journal of Tropical Medicine and Hygiene, vol. 55, no. 5, pp. 477–481, 1996. View at Google Scholar
  11. J. R. Torres, R. Isturiz, J. Murillo, M. Guzman, and R. Contreras, “Efficacy of ivermectin in the treatment of strongyloidiasis complicating AIDS,” Clinical Infectious Diseases, vol. 17, no. 5, pp. 900–902, 1993. View at Google Scholar
  12. D. Nonaka, K. Takaki, M. Tanaka et al., “Paralytic ileus due to strongyloidiasis: case report and review of the literature,” The American Journal of Tropical Medicine and Hygiene, vol. 59, no. 4, pp. 535–538, 1998. View at Google Scholar
  13. L. M. Fox, “Ivermectin: uses and impact 20 years on,” Current Opinion in Infectious Diseases, vol. 19, no. 6, pp. 588–593, 2006. View at Publisher · View at Google Scholar · View at PubMed
  14. F. M. Marty, C. M. Lowry, M. Rodriguez et al., “Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectin,” Clinical Infectious Diseases, vol. 41, no. 1, pp. e5–e8, 2005. View at Publisher · View at Google Scholar · View at PubMed
  15. J. H. Maguire, “Intestinal nematodes (roundworms),” in Principles and Practice of Infectious Diseases, G. L. Mandell, J. E. Bennett, and R. Dolin, Eds., pp. 3260–3266, Elsevier, Philadelphia, Pa, USA, 6th edition, 2005. View at Google Scholar
  16. O. Zaha, T. Hirata, F. Kinjo, and A. Saito, “Strongyloidiasis-progress in diagnosis and treatment,” Internal Medicine, vol. 39, no. 9, pp. 695–700, 2000. View at Publisher · View at Google Scholar
  17. A. Nath and J. R. Berger, Eds., Clinical Neurovirology, A. Nath and J. R. Berger, Eds., Marcel Dekker, New York, NY, USA, 1st edition, 2003.
  18. D. Kitzman, S.-Y. Wei, and L. Fleckenstein, “Liquid chromatographic assay of ivermectin in human plasma for application to clinical pharmacokinetic studies,” Journal of Pharmaceutical and Biomedical Analysis, vol. 40, no. 4, pp. 1013–1020, 2006. View at Publisher · View at Google Scholar · View at PubMed
  19. L. I. Neefe, O. Pinilla, V. F. Garagusi, and H. Bauer, “Disseminated strongyloidiasis with cerebral involvement: a complication of corticosteroid therapy,” The American Journal of Medicine, vol. 55, no. 6, pp. 832–838, 1973. View at Publisher · View at Google Scholar
  20. L. W. Kitchen, K. K. Tu, and F. T. Kerns, “Strongyloides-infected patients at Charleston area medical center, West Virginia, 1997-1998,” Clinical Infectious Diseases, vol. 31, no. 3, pp. E5–E6, 2000. View at Publisher · View at Google Scholar · View at PubMed
  21. A. A. Gam, F. A. Neva, and W. A. Krotoski, “Comparative sensitivity and specificity of ELISA and IHA for serodiagnosis of Strongyloides with larval antigens,” The American Journal of Tropical Medicine and Hygiene, vol. 37, no. 1, pp. 157–161, 1987. View at Google Scholar
  22. J. F. Lindo, N. S. Atkins, M. G. Lee, R. D. Robinson, and D. A. P. Bundy, “Parasite-specific serum IgG following successful treatment of endemic strongyloidiasis using ivermectin,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 90, no. 6, pp. 702–703, 1996. View at Publisher · View at Google Scholar
  23. T. W. Gyorkos, R. M. Genta, P. Viens, and J. D. MacLean, “Seroepidemiology of Strongyloides infection in the Southeast Asian refugee population in Canada,” American Journal of Epidemiology, vol. 132, no. 2, pp. 257–264, 1990. View at Google Scholar
  24. C. A. Guzzo, C. I. Furtek, A. G. Porras et al., “Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects,” The Journal of Clinical Pharmacology, vol. 42, no. 10, pp. 1122–1133, 2002. View at Google Scholar
  25. S. A. Turner, J. D. MacLean, L. Fleckenstein, and C. Greenaway, “Parenteral administration of ivermectin in a patient with disseminated strongyloidiasis,” The American Journal of Tropical Medicine and Hygiene, vol. 73, no. 5, pp. 911–914, 2005. View at Google Scholar
  26. D. W. Fink and A. G. Porras, “Pharmacokinetics of ivermectin in animals and humans,” in Ivermectin and Abamectin, pp. 113–130, Springer, New York, NY, USA, 1989. View at Google Scholar
  27. J. Pacanowski, M. Dos Santos, A. Roux et al., “Subcutaneous ivermectin as a safe salvage therapy in Strongyloides stercoralis hyperinfection syndrome: a case report,” The American Journal of Tropical Medicine and Hygiene, vol. 73, no. 1, pp. 122–124, 2005. View at Google Scholar
  28. P. L. Chiodini, A. J. C. Reid, M. J. Wiselka, R. Firmin, and J. Foweraker, “Parenteral ivermectin in Strongyloides hyperinfection,” The Lancet, vol. 355, no. 9197, pp. 43–44, 2000. View at Publisher · View at Google Scholar